References
- Peterson LS, Nelson AM, Daniel Su WP, Mason T, O'Fallon WM, Gabriel SE. The epidermology of morphea (localized scleroderma) in Olmsted country 1960–1993. J Ftheumatol 1997;24: 73–80.
- Uziel Y, Krafchik BR, Silverman ED, Thorner PS. Localized scle-roderma in children: a report of 30 cases. Semin Arthritis Rheum 1994;23:328–40.
- Yamanaka CT, Gibbs NF. Trauma-induced linear scleroderma. Cutis 1999;63:29–32.
- Hauser C, Skaria A, Harms M, Saurat JH. Morphea following Blaschiko's lines. Br J Dermatol 1996;134:594–5.
- Torok E, Ablnnzy E. Morphea in children. Clin Exp Dermatol 1986;11:607–12.
- Falanga V, Medsger TA Jr, Reichlin M. Localized scleroderma: clinical spectrum, prognosis and laboratory abnormalities. Ann Intern Med 1986;104:849–57.
- Sato S, Ihn H, Soma Y, Igarashi A, Tamaki T, Kikuchi K, et al. Antihistone antibodies in patients with localized scleroderma. Arthritis Rheum 1993;36:1137–41.
- Takehara K, Moroi Y, Nakabayashi Y, Ishibashi Y. Antinuclear antibodies in localized scleroderma. Arthritis Rheum 1983;26: 612–6.
- Falanga V, Medsger TA Jr, Reichlin M. Antinuclear antibodies and anti-single-stranded DNA antibodies in morphea and general-ized morphea. Arch Dermatol 1987;123:350–3.
- Takehara K, Ihn H, Sato S, Tamaki T, Kikuchi K, Igarashi A, et al. Anti-ss DNA antibodies in localized scleroderma: two cases in which changes of the titers were referential in the treatment (in Japanese). Ftinsho Derma (Tokyo) 1993;35:737–40.
- Kachanek KS, Goldermann R, Lehmann P, Holzle E, Goerz G. PUVA therapy in disabling pansclerotic morphea of children. Br J Dermatol 1995;132:830.
- Krafchik BR. Localized morphea in children. Adv Exp Med Biol 1999;455:49–54.
- Birdi N, Shore A, Rush P, Laxer RM, Silverman ED, Krafchik B. Childhood linear scleroderma: a possible role of thermography for evaluation. J Ftheumatol 1992;19:968–73.